This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Tale of the Tape: Archive
Open Lending (LPRO) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Open Lending (LPRO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
LPROPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Are You Looking for a Top Momentum Pick? Why ITT (ITT) is a Great Choice
by Zacks Equity Research
Does ITT (ITT) have what it takes to be a top stock pick for momentum investors? Let's find out.
ITTNegative Net Change
momentum-investor momentum-stocks price-change volume
GEN or ZETA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GEN vs. ZETA: Which Stock Is the Better Value Option?
GENPositive Net Change ZETANegative Net Change
value-stocks which-stock-is-cheaper
PCG vs. CNP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PCG vs. CNP: Which Stock Is the Better Value Option?
PCGPositive Net Change CNPPositive Net Change
value-stocks which-stock-is-cheaper
RTO or TRI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
RTO vs. TRI: Which Stock Is the Better Value Option?
RTONegative Net Change TRIPositive Net Change
value-stocks which-stock-is-cheaper
EXPE vs. MELI: Which Stock Is the Better Value Option?
by Zacks Equity Research
EXPE vs. MELI: Which Stock Is the Better Value Option?
EXPENegative Net Change MELIPositive Net Change
value-stocks which-stock-is-cheaper
G or NOW: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
G vs. NOW: Which Stock Is the Better Value Option?
GPositive Net Change NOWNegative Net Change
value-stocks which-stock-is-cheaper
MTG or ZURVY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MTG vs. ZURVY: Which Stock Is the Better Value Option?
MTGPositive Net Change ZURVYPositive Net Change
value-stocks which-stock-is-cheaper
ALKS or ILMN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALKS vs. ILMN: Which Stock Is the Better Value Option?
ALKSPositive Net Change ILMNPositive Net Change
value-stocks which-stock-is-cheaper
Analysts Estimate Energizer Holdings (ENR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Energizer (ENR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ENRPositive Net Change EPCNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Star Bulk Carriers (SBLK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Star Bulk Carriers (SBLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SBLKPositive Net Change EDRYNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
ACCESS Newswire Inc. (ACCS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
ACCESS Newswire Inc. (ACCS) delivered earnings and revenue surprises of +33.33% and +1.29%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
ACCSPositive Net Change AENTNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Amer Sports, Inc. (AS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Amer Sports, Inc. (AS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ASPositive Net Change ONEWPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Home Depot (HD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Home Depot (HD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HDPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade
by Zacks Equity Research
The consensus price target hints at a 108.5% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ADMAPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 32.69% Upside in Chemed (CHE): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Chemed (CHE) points to a 32.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
CHEPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 26.46% Upside in Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST): Here's What You Should Know
by Zacks Equity Research
The mean of analysts' price targets for Vista Energy, S.A.B. de C.V. - Sponsored ADR (VIST) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
VISTPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
BWX (BWXT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for BWX (BWXT), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
BWXTNegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Here's Why Pure Storage (PSTG) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Pure Storage (PSTG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
PSTGNegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Webtoon (WBTN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Webtoon (WBTN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
WBTNNegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Wall Street Analysts Predict a 124.3% Upside in Lexeo Therapeutics, Inc. (LXEO): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 124.3% upside potential for Lexeo Therapeutics, Inc. (LXEO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
LXEOPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does NextCure (NXTC) Have the Potential to Rally 107.88% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 107.9% in NextCure (NXTC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NXTCPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Aris Mining Corporation (ARMN) Have the Potential to Rally 51.25% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 51.3% upside potential for Aris Mining Corporation (ARMN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ARMNPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Here's Why Silicon Motion (SIMO) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
SIMONegative Net Change
momentum-investor momentum-stocks top-ranked
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IQVPositive Net Change
momentum-investor momentum-stocks top-ranked